Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Server Hande Çağlayan"'
Autor:
İnanç Değer Fidancı, Bülent Zülfikar, Kaan Kavaklı, M. Cem Ar, Yurdanur Kılınç, Zafer Başlar, Server Hande Çağlayan
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 1, Pp 17-24 (2014)
OBJECTIVE: A severe complication in the replacement therapy of hemophilia A (HA) patients is the development of alloantibodies (inhibitors) against factor VIII, which neutralizes the substituted factor. The primary genetic risk factors influencing th
Externí odkaz:
https://doaj.org/article/6b0ddb0d7b264ab9807c7d3153020d58
Autor:
Herbert Schulz, Zuhal Yapici, Nihan Hande Akçakaya, Server Hande Çağlayan, Thomas Sander, Özlem Yalçın Çapan
Publikováno v:
Epileptic Disorders. 19:217-221
Çapan Yalçın, Özlem (Arel Author)
The 8p23.1 deletion syndrome is a rare multisystem disorder with high penetrance and a variable phenotypic spectrum that includes congenital heart disease (CHD), intellectual disability, behavioural problems
The 8p23.1 deletion syndrome is a rare multisystem disorder with high penetrance and a variable phenotypic spectrum that includes congenital heart disease (CHD), intellectual disability, behavioural problems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b1e8a8c523fd8b7afa41c45d634a00
https://doi.org/10.1684/epd.2017.0906
https://doi.org/10.1684/epd.2017.0906
Autor:
Ozlem Yalcin, Derya Uluduz, Demet Yandim Kuscu, Günay Gül, Zuhal Yapici, Kadriye Agan, Server Hande Çağlayan, Cihan Meral, Semih Ayta, Destina Yalcin, Betül Baykan, Aycan Ünalp, Gulsen Dizdarer, Sinan Çomu, Cigdem Ozkara, Kemal Tutkavul, Dilsad Turkdogan, Burak Tatlı, Nerses Bebek
Publikováno v:
Epilepsia. 52:975-983
Summary Purpose: To further evaluate the previously shown linkage of absence epilepsy (AE) to 2q36, both in human and WAG/Rij absence rat models, a 160-kb region at 2q36 containing eight genes with expressions in the brain was targeted in a case–co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::170419325fe3cc5d4c68343eb16d1e61
https://doi.org/10.1111/j.1528-1167.2010.02970.x
https://doi.org/10.1111/j.1528-1167.2010.02970.x
Autor:
Server Hande Çağlayan, Kaan Kavakli, Zafer Baslar, Bulent Zulfikar, İnanç Değer Fidancı, Yurdanur Kilinç, M. Cem Ar
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 1, Pp 17-24 (2014)
Turkish Journal of Hematology
Turkish Journal of Hematology
WOS: 000347435400003
PubMed ID: 24764725
Objective: A severe complication in the replacement therapy of hemophilia A (HA) patients is the development of alloantibodies (inhibitors) against factor VIII, which neutralizes the substituted fact
PubMed ID: 24764725
Objective: A severe complication in the replacement therapy of hemophilia A (HA) patients is the development of alloantibodies (inhibitors) against factor VIII, which neutralizes the substituted fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353b8d06aa2d82e47b6a280a546679a1
https://hdl.handle.net/11454/50266
https://hdl.handle.net/11454/50266
